title: Defining value-driven care in head and neck oncology.
abstract: In the USA, increasing attention is being paid to adopting a value-based framework for measuring and ultimately improving health care delivery. Value is defined as the benefit achieved relative to costs. The numerator of the value equation includes quality of care and outcomes achieved. The denominator includes costs, both financial costs and harms of treatment. Herein, we describe these elements of value as they pertain to head and neck cancer. A particular focus is to identify areas of the value equation where physicians have some control. We examine quality in each of three dimensions: structure, process, and outcomes. We also adopt Porter's three-tiered hierarchy of outcomes model, with specific outcomes relevant to patients with head and neck and thyroid cancer. Finally, we review issues related to costs and harms. We believe these findings can serve as a framework for further efforts to drive value-based delivery of head and neck cancer care.
authors.affiliation: Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA, romanb@mskcc.org.
authors.forename: Benjamin R
authors.initials: BR
authors.lastname: Roman
authors.forename: Mahmoud I
authors.initials: MI
authors.lastname: Awad
authors.forename: Snehal G
authors.initials: SG
authors.lastname: Patel
mesh_terms: D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D019317:Evidence-Based Medicine; D006258:Head and Neck Neoplasms / Q000191:economics / Q000628:therapy*; D017048:Health Care Costs; D006801:Humans; D011787:Quality of Health Care / Q000592:standards*; D014481:United States